Friday, 19 February 2016

Cardiovascular diseases, including heart attacks and strokes, continue to be the leading causes of deaths resulting in more than 17 million deaths each year worldwide. Cardiovascular disease (CVD) manifests as atherosclerosis, high cholesterol, high blood pressure, arrhythmia, and heart failure and has many more symptoms affecting the heart and blood vessels. Additionally, other metabolic diseases such as obesity and diabetes further increase the risk of CVD.

Wednesday, 12 February 2014

Influenza (flu) is a common viral disease affecting up to 20% of the world’s population. In most cases, the flu is benign, but it can also have serious consequences especially in people with compromised immune systems, the elderly, and children. It is estimated to cause 250,000 to 500,000 deaths worldwide each year1.

The flu virus easily spreads through the air or by direct contact. In most cases, simple measures such as frequent hand washing and good nutrition are effective in preventing the flu. However, every year media fuelled campaigns promote influenza vaccination as the best protection against the flu. The influenza vaccine global market generates close to $3 billion a year and it is estimated to reach $4.2 billion by the end of 2014. Despite aggressive marketing it has been difficult to prove the efficacy of the flu vaccine since the flu virus frequently mutates (changes) and resistance to the vaccines is very common.

Sunday, 19 January 2014

In the US alone, 2.7 million people are at risk of a serious stroke and other health problems triggered by irregular heartbeat or arrhythmia. The most common form of arrhythmia is atrial fibrillation, which contributes to 80,000 deaths annually in the US. It is predicted that by 2050 as many as 12 million people will be affected by this condition. Treatment of atrial fibrillation is associated with tremendous cost for the patient and our health care system.

The American Heart Association’s 2011 report states the government’s cost associated with treating atrial fibrillation ranges from $6-$26 billion a year.

 Atrial fibrillation occurs when the cells that create or conduct the biological electricity of the heart beat are not functioning properly. This can be manifested by rapid or irregular heartbeat, palpitation, dizziness and in severe cases shortness of breath, and chest pain. This condition affects the elderly, people with diabetes, high blood pressure, thyroid abnormalities, or any type of heart disease, as well as younger athletes.

In any form of irregular heartbeat, you should consult with your doctor. However, do not be surprised that conventional medicine cannot always identify the root cause of this problem, mainly because it misses the most common cause of the malfunction in the metabolism of cardiac cells.

Considering the lack of satisfactory options, we evaluated the possibility that the dysfunction of the heart muscle cells may be a result of a long-term deficiency of vitamins and other micronutrients, which are the key carriers of bioenergy in the metabolism of heart cells. Such deficiency especially affects the “electrical” cells of the heart, which need large amounts of energy to create the electrical impulse for a heartbeat. Optimum bioenergy generation in cells depends on micronutrients such as, vitamin C, lysine, CoQ10, carnitine, the B vitamins, and many others.

Our double-blind placebo controlled multi-center clinical study* involved 131 patients between 18 and 70 who were taking anti-arrhythmic medications with little success. All participants were randomly divided into two groups: half took a multi-nutrient program daily and half an identically looking placebo. Evaluation after three and six months of the study showed that after just three months, about 23% of the participants taking supplements experienced a decrease of arrhythmic episodes and after six months, this number almost doubled to 43%. Other study participants in the supplement group experienced a significant decrease in the frequency of arrhythmic episodes. In addition, there was a remarkable improvement in their quality of life as shown by a specific questionnaire.

The results of this clinical study bring hope for millions of people suffering from atrial fibrillation and those who want to maintain healthy heart function.  

* M. Rath, T. Kalinovsky, A. Niedzwiecki
Journal of the American Nutraceutical Association 2005, 8(3): 19-25

 

printablesummarystudy

Page 2 of 2